WithdrawnNot Applicable

Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy

Taiwan0Started 2011-08

Plain-language summary

The investigators used two different doses of esomeprazole (40 mg IV q.d. and 40 mg IV q6h for three days followed by esomeprazole 40 mg q.d. orally in two groups) after successful endoscopic therapy with heat probe therapy or hemoclip placement. The goal of this study is to assess the outcomes of two different regimens of low vs. high dose of intravenous esomeprazole after endoscopic therapy in patients with peptic ulcer bleeding.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with peptic ulcer bleeding with active bleeding or nonbleeding visible (initial Hb\<10, shock, or coffee grounds or blood in stomach) Exclusion Criteria: * age \>90y/o * pregnant woman * allergic to esomeprazole * unwilling to enter this study * bleeding tendency * severe co-morbid illness, including cancer, hepatic failure, renal failure,

What they're measuring

further bleeding

Timeframe: 14 days

Trial details

NCT IDNCT04407832

SponsorChanghua Christian Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-07

View on ClinicalTrials.gov More Peptic Ulcer Bleeding trials